£1.9 million funding supports research on drivers of health disparities and infection risk across England

Dr Rosalind Eggo, an Associate Professor of Infectious Disease Modelling at the London School of Hygiene & Tropical Medicine (LSHTM), has been awarded over £1.9 million funding to lead research into drivers of health disparities and associated infectious disease burden across England.

Guselkumab Continues Winning Streak in Crohn’s Disease

WASHINGTON — Induction and maintenance treatment with guselkumab (Tremfya) demonstrated its safety and efficacy for patients with moderately to severely active Crohn’s disease, topping both

May 23, 2024

Therapeutic potential of human umbilical cord-derived mesenchymal stem cells in Crohn’s disease

Whether human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) could heal luminal ulcers in Crohn’s disease.

April 25, 2024

Hospital systems have to decide: Do they want to be Apple or Android?

Convenience is rapidly becoming a guiding principle for hospital system strategy and competition. As patients demand a more convenient, integrated care experience, and new partnerships/acquisitions

November 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.